Transapical transcatheter aortic valve implantation: 1-year outcome in 26 patients Jian Ye, MD, Anson Cheung, MD, Samuel V. Lichtenstein, MD, PhD, Lukas A. Altwegg, MD, Daniel R. Wong, MD, Ronald G. Carere, MD, Christopher R. Thompson, MD, Robert R. Moss, MD, Brad Munt, MD, Sanjeevan Pasupati, MD, Robert H. Boone, MD, Jean- Bernard Masson, MD, Abdullah Al Ali, MD, John G. Webb, MD The Journal of Thoracic and Cardiovascular Surgery Volume 137, Issue 1, Pages 167-173 (January 2009) DOI: 10.1016/j.jtcvs.2008.08.028 Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Three major components of the transapical aortic valve implantation: balloon valvuloplasty, deployment, and assessment of the prosthetic valve. TEE, Transesophageal echocardiography. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 167-173DOI: (10.1016/j.jtcvs.2008.08.028) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Twelve-month follow-up of echocardiographic parameters and New York Heart Association (NYHA) functional class in 17 patients surviving more than 12 months (matched data). ∗P < .0001 versus preoperative baseline. MR, Mitral regurgitation; Pre-op, preoperative; Post-op, postoperative; AR, aortic regurgitation. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 167-173DOI: (10.1016/j.jtcvs.2008.08.028) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 Kaplan–Meier survival. Pts, Patients. The Journal of Thoracic and Cardiovascular Surgery 2009 137, 167-173DOI: (10.1016/j.jtcvs.2008.08.028) Copyright © 2009 The American Association for Thoracic Surgery Terms and Conditions